Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
The podcast can be downloaded here and is embedded below. Subscribe to the podcast via Apple Podcast, Google Play, Spotify or the RSS feed. Updates on the podcast on Twitter at @Lawbytespod.
Credits:
CTV News, Canada’s Chief Public Health Officer Says a Coronavirus Vaccine is ‘Probably’ a Year Away
The world has been focused for the past several weeks on racial justice and the Black Lives Matter movement, with millions around the world...
The Citizen Lab at the University of Toronto, led by Professor Ron Deibert, has a well-earned reputation for uncovering surveillance technologies and security vulnerabilities...
Last month, Canada’s telecom regulator, the CRTC, issued its final decision in a lengthy battle over the rates that independent Internet providers pay for...